A revascularização cardíaca utilizando a ponte de safena é um procedimento bastante comum usado para restabelecer o fluxo coronariano. O sucesso do implante depende da adaptação do vaso que estava em um regime hemodinâmico venoso, e passa subitamente para um regime arterial. Durante este processo adaptativo, ocorrem diversas alterações moleculares cujo conhecimento pode fornecer alternativas de melhoramento da patência dos enxertos venosos em leito arterial. Neste trabalho está sendo investigada a regulação da IL-1beta tanto em veia safena humana como em modelo animal de arterialização venosa. A IL-1beta mostrou-se aumentada em veia safena humana arterializada tanto in vivo como ex vivo. Interessantemente, este aumento observado nos dias iniciais (1-5 dias) parece diminuir em tempos mais tardios (1-4 anos). Em modelo de arterialização de rato foi observado aumento de 12 vezes na expressão da IL-1beta após o primeiro dia de arterialização com diminuição posterior, mantendo-se em torno de 2 vezes maior em comparação a veia jugular normal. Além da regulação temporal da IL-1beta, foram também acompanhadas as alterações morfológicas que ocorrem durante o processo de arterialização venosa. Observou-se uma redução gradual de células musculares lisas (SMC) que quase desaparecem 3 dias após a cirurgia. Esta perda celular pode estar relacionada ao pico de apoptose observado já no primeiro dia de arterialização. Após 7 dias as SMC reaparecem, porém, de maneira ainda desorganizada. Concomitante com o reaparecimento das SMC observou-se progressivo espessamento da camada média, assim como surgimento de uma camada neoíntima. A IL-1beta, devido ao seu padrão de regulação assim como sua localização durante o processo de arterialização, pode estar relacionada com as alterações estruturais verificadas na arterialização do enxerto. Estratégias de intervenção modulando a atividade da IL-1beta poderão fornecer indicativos da sua participação no remodelamento do enxerto venoso. Em conjunto, demonstramos que o modelo de arterialização de segmento venoso em rato reproduz várias das alterações morfológicas descritas na doença do enxerto venoso em humanos e por isso será útil na caracterização de genes candidatos que participam deste processo. A IL-1beta tem sua expressão aumentada em segmento venoso arterializado in vivo e ex vivo, podendo representar um interessante alvo para aplicação de metodologias de intervenção visando influenciar a adaptação de enxertos venosos com finalidade terapêutica / The vein graft is subjected to increased tensile stress and the complex adaptive vein response to the arterial hemodynamic condition may predispose to bypass failure in some individuals. The understanding of molecular changes underlying this process may be useful for the development of novel therapeutical interventions to increase the vein graft patency. In this work, we investigated the early effect of arterialization on the expression of IL-1beta gene in human saphenous vein and the time-course regulation in rat arterialization model. IL-1beta is upregulated in early stage of human saphenous vein arterialization in vivo and ex vivo. This increase is also observed in arterialized rat jugular vein which showed IL-1beta expression 12 times higher on day 1 compared to normal jugular vein. Later, the IL-1beta levels decreases and maintain the level about twice above normal jugular vein. Moreover, it is observed gradual reduction of smooth muscle cells (SMC), which almost disappeared on the 3rd day after surgery. Apoptosis, which is markedly increased on the 1st day, appears to be an important event during this process. At the 7th day, cellular density and SMC proliferation gradually increased till the 90th day. There was a gradual thickening of the medial layer and formation of neointima with deposition of SMC in the subendotelial layer from day 7 on. Initially the medial layer appeared disorganized, day 7 to 14, then by day 28 it became more organized and the presence of an intimal layer with SMCs was evident. The neointimal layer increased gradually from day 7 on. These results provide evidence that the modulation of IL-1beta activity may be an interesting target to be explored I the future to increase the vein graft patency. Altogether, we demonstrate that the model of arterialization of venous segment in rat reproduces several of the morphological changes described in the venous graft disease in humans and thus will be useful in characterization of candidate genes involved in this process and testing them as a potential therapeutic targets. The IL-1beta expression is increased after 1 day of arterialization of vein segment in vivo and ex vivo and shall be an interesting target to be tested to influence the adaptation of venous grafts for therapeutic purpose

This project offers evidence and data to measure how progressive and sustained mobilization strategies that are implemented by nurses impact early discharge on a single stay Cardiothoracic Intensive Care Unit for patients undergoing first-time Coronary Artery Bypass Surgery (CABG) surgery.

Indiana University-Purdue University Indianapolis (IUPUI) / Introduction: Regenerative endodontic therapy in immature teeth with necrotic pulps triggers continued root development thereby improving the prognosis of these teeth. Several agents are under consideration for the disinfection and conditioning phases of this therapy. Triple antibiotic paste (TAP, i.e. equal parts of ciprofloxacin, metronidazole, minocycline) is used for canal disinfection and 17% EDTA solution is used for dentin conditioning. However, TAP and EDTA cause demineralization and their effect on surface loss and surface roughness of radicular dentin during regenerative procedures has not been quantified. Surface loss may be correlated with reduced tooth strength and surface roughness may be correlated with stem cell attachment. Objectives: The aim of this in vitro study was to quantitatively investigate the surface loss and surface roughness on human radicular dentin after treatment with two concentrations of TAP followed by EDTA. Materials and Methods: Human radicular dentin specimens were prepared from extracted human anterior teeth and randomized into six experimental groups. Group 1: saline control; Group 2: 17% EDTA; Group 3: TAP 1 mg/mL; Group 4: TAP 1 mg/mL and 17% EDTA; Group 5: TAP 1,000 mg/mL; Group 6: TAP 1,000 mg/mL and 17% EDTA for 5 minutes. After TAP is applied to Groups 3-6, all groups were incubated for 4 weeks. Then, groups 2, 4, and 6 were treated with EDTA for 5 minutes. Dentin surface loss (μm) and surface roughness (Ra, μm) were quantified after various treatments using non-contact and contact profilometry, respectively. Data were analyzed by one-way analysis of variance (α = 0.05) Hypothesis: It was hypothesized that there would be a significant difference in surface loss or surface roughness between at least two treatment groups. Results: All treatment groups showed significantly higher surface loss compared to untreated control. Dentin treated with 1g/mL TAP caused significant increase in surface loss and surface roughness compared to dentin treated with 1 mg/mL TAP. However, only 1g/mL TAP treated dentin showed significantly higher surface roughness compared to untreated control. The use of EDTA after both concentrations of TAP did not have significant additive effect on surface loss and surface roughness of dentin. Conclusion: The use of 1 mg/mL TAP can minimize surface loss and surface roughness of radicular dentin compared to higher concentrations. The use of EDTA after TAP may not cause additional surface loss and surface roughness of dentin.

Indiana University-Purdue University Indianapolis (IUPUI) / Coronary artery disease (CAD) is a leading cause of death among Americans and is fueled by underlying metabolic syndrome (MetS). The prevalence and lethality of CAD necessitates rigorous investigations into its underlying mechanisms and to facilitate the development of effective treatment options. Coronary smooth muscle (CSM) phenotypic modulation from quiescent to synthetic, proliferative, and osteogenic phenotypes is a key area of investigation, with underlying mechanisms that remain poorly understood. Using a well-established pre-clinical model of CAD and MetS, the Ossabaw miniature swine, we established for the first time the time course of Ca2+ dysregulation during MetS-induced CAD progression. In particular, we used the fluorescent Ca2+ dye, fura-2, to examine alterations in CSM intracellular Ca2+ regulation during CAD progression, as perturbations in intracellular Ca2+ regulation are implicated in several cellular processes associated with CAD pathology, including CSM contractile responses and proliferative pathways. These studies revealed that the function of several CSM Ca2+ handling proteins is elevated in early CAD, followed by loss of function in severe atherosclerotic plaques. Decreased intracellular Ca2+ regulation occurred concurrently with reductions in CSM proliferation, measured with Ki-67 staining. In particular, alterations in sarcoplasmic reticulum (SR) Ca2+ store together with altered function of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) were associated with induction of proliferation. Organ culture of coronary arterial segments revealed that culture-induced medial thickening was prevented by SERCA inhibition with cyclopiazonic acid (CPA). Activation of SERCA with the small molecule activator, CDN1163, increased CSM proliferation, which was attenuated by treatment with CPA, thus establishing upregulated SERCA function as a proximal inducer of CSM proliferation. Further, we demonstrated that in vitro treatment of CSM from lean Ossabaw swine with the glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, increased SERCA function. However, in vivo treatment of Ossabaw swine with MetS with the GLP-1 receptor agonist, AC3174, had no effect on CAD progression and in vitro examination revealed resistance of SERCA to GLP-1 receptor agonism in MetS. These findings further implicate SERCA in CAD progression. Collectively, these are the first data directly linking SERCA dysfunction to CSM proliferation and CAD progression, providing a key mechanistic step in CAD progression.

Pancreatic transplantation is the only possible treatment to induce independence from exogenous insulin administration in type 1 diabetes mellitus. However, the shortage of donor organs remains the main limitation of pancreas transplantations. The goal of the research is the preparation of a bioartificial organ based on cell therapy. Parts of the extracellular matrix obtained by decellularization of the pancreas are used for its preparation. The protein scaffolds prepared in this way are then repopulated by different cell types again. The extracellular matrix provides structural support to cells, mediates signaling for differentiation, proliferation or migration. Mesenchymal stromal cells are used in clinical therapy, have a positive effect on tissue regeneration processes, modulating the function of the extracellular matrix, suppress inflammation and promote angiogenesis. After pancreas decellularization, we repopulated the extracellular matrix with islets, mesenchymal cells and endothelial cells. Then, the pancreas was transplanted subcutaneously into syngeneic diabetic rats to observe islet revascularization. Based on sections of explanted scaffolds, we found out that revascularization of the islets was higher without the endothelial cells in the transplanted extracellular matrix. Key words:...

Mild cognitive deficits that negatively impact self-management education-related outcomes may be present in a proportion of cardiac rehabilitation patients and the degree of impairment may vary by the type of coronary revascularization procedure. The purpose of this study was to compare cognitive function, as measured by the Montreal Cognitive Assessment (MoCA), between coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) patients, and to determine independent variables of MoCA score. In a cross-sectional study, 78 cardiac rehabilitation patients (CABG n = 38, PCI n = 40) completed the MoCA. Demographics were collected and disease burden was calculated using the age-adjusted Charlson Comorbidity Index (ACCI). Mild cognitive deficits (MoCA ≤26) were present in 55.3% CABG and 30.0% PCI patients. An independent Student’s t test showed that MoCA scores were significantly lower among CABG patients (mean = 24.5, SD = 3.3) compared to PCI patients (M = 26.7, SD = 2.7), t (76) = 3.15, p < 0.01. Descriptive analyses of cognitive domain scores indicated that deficits in short-term memory and language were present among CABG patients. Using a backward regression, coronary revascularization procedure (CABG vs. PCI) (p = 0.006) and disease burden (ACCI) (p = 0.015) remained significant, while heart failure diagnosis became non-significant and was removed from the model (F (2, 75) = 8.382, p < 0.001). The final model explained 16.1% of the total variance in MoCA score (adjusted R2 = 0.161). Results indicate that cognitive deficits were present in cardiac rehabilitation participants and associated with the type of coronary revascularization procedure, suggesting the need for formal cognitive screening and adaptation of education interventions in cardiac rehabilitation. A future prospective cohort study is required to establish temporality, and to measure education-related outcomes, such as health-related quality of life (HRQOL) and self-management. / Thesis / Master of Science (MSc) / Cardiac rehabilitation (CR) is a multifaceted program consisting of exercise and education that is essential to the care of post-coronary revascularization patients. While exercise has shown to improve health outcomes, education has demonstrated inconsistent effects. Since education has imposed cognitive demands, this discrepancy in outcomes may, in part, be due to cognitive deficits present in a proportion of program attendees: the degree of impairment may vary by type of coronary revascularization procedure prior to CR. This study compared cognitive function between two groups of coronary revascularization patients, post-coronary bypass surgery and post-coronary angioplasty, and determined independent variables for cognitive function. Results showed that coronary bypass surgery patients had significantly lower cognitive function than coronary angioplasty patients at program intake. Coronary bypass surgery and accumulated disease burden were weakly associated with decreased cognitive function. Cognitive screening and adapted education for patients with cognitive deficits should be considered to improve CR outcomes.

Made available in DSpace on 2016-01-26T12:51:53Z (GMT). No. of bitstreams: 1 paulorogeriocorrea_tese.pdf: 1233217 bytes, checksum: 4e4b574f24af12fb3446f5336ad9af00 (MD5) Previous issue date: 2006-12-01 / Heart Rate Variability (HRV) is the most frequently used non-invasive diagnostic method for evaluating the heart autonomic control. Taking into consideration that the autonomous nervous system modulates, in an important way, the cardiovascular function, any alteration in the autonomous cardiovascular function constitutes cause and/or coadjuvant condition for numerous diseases. Recent studies have shown that through the heart frequency variability, by evaluating it within time, frequency and chaos domain, the human organisms, generally speaking, show a behavior of nonlinear complex systems, thus following the laws of Chaos Theory. The HRV analysis, by other nonlinear dynamic methods in the myocardial revascularization surgery pre-operation period, could predict more morbidity in the post-operation period, for example, lung infections. Objective: Evaluate the heart rate variability (HRV) behavior in the chaos domain (nonlinear dynamic) in the preoperative period of surgical myocardial revascularization and its relationship to lung infections occurrences in postoperative stay. Casuistic and Method: 72 non-selected patients were studied (age range from 58.4±10.2 years old) with coronary artery disease and having elective surgery indication for myocardial revascularization. In order to quantify the HRV in the chaos domain, the Detrended Fluctuation Analysis (DFA total) variables, their short-term (&#945;1) and long-term (&#945;2) correlations, Approximate Entropy (-ApEn), Lyapunov Exponent (LE), self-correlation (Tau), Normalized Tau (nT) and Hurst Exponent (HE) were measured in temporal series of 1.000 RR intervals of electrocardiogram recorded on the day before the operation, with Polar S810i equipment. Results: The cut-off levels were determined with help from ROC curve being for DFA total, &#945;1, &#945;2, Approximate Entropy, Lyapunov Exponent, Tau, Normalized Tau and Hurst Exponent, respectively: &#61619;1.036917, &#61619; 0.727273, &#61619; 0.906397, &#61603; 0.480176, &#61603; 0.832, &#61603; 28.23143, &#61619;11.312504, &#61603; and 0.210447. In the Chaos Domain, the DFA total, Normalized Tau , Approximate Entropy and Lyapunov Exponent in the pre-operation period, were associated with the lung infection occurrences in the postoperative period with P =0.0309, P=0.0232, P= 0.0307 and P= 0.0006, respectively. In conclusion, the nonlinear dynamic methods, in their respective cut-off levels, allowed differentiating the cases that evolved into lung infection in the postoperative period of surgical myocardial revascularization. / A Variabilidade da freqüência cardíaca (HRV Heart Rate Variability ) é o método diagnóstico não invasivo mais freqüentemente usado na avaliação do controle autonômico do coração. Considerando que o sistema nervoso autônomo modula, de maneira importante, a função cardiovascular, as alterações na função autonômica cardiovascular constituem causa e/ou condição coadjuvante de numerosas doenças. Estudos recentes têm mostrado que pela análise da variabilidade da freqüência cardíaca, avaliando-a nos domínios do tempo, da freqüência e do caos, os organismos humanos, de forma geral, comportam-se como sistemas complexos não-lineares, obedecendo-se, assim, às leis da Teoria do Caos. A análise da HRV por outros métodos de dinâmica não linear no período pré-operatório da cirurgia de revascularização do miocárdio poderia ser preditora de maior morbidade no pós-operatório, como por exemplo, infecções pulmonares. Objetivo: Avaliar o comportamento da variabilidade da freqüência cardíaca (HRV) no domínio do caos (dinâmica não-linear) no período pré-operatório da cirurgia de revascularização do miocárdio e sua relação com a ocorrência de infecções pulmonares no período pós-operatório hospitalar. Casuística e Método: Foram estudados 72 pacientes não-selecionados (média de idade de 58,4±10,2 anos) com doença arterial coronária e indicação eletiva de cirurgia de revascularização do miocárdio. Para quantificar a dinâmica da HRV no domínio do caos foram medidas as variáveis, Análise das Flutuações Depuradas de Tendências (DFA total), seus componentes de curto (&#945;1) e longo (&#945;2) prazos, Entropia Aproximada (-ApEn), Expoente de Lyapunov (LE), Autocorrelação (Tau), Tau normalizado e Expoente de Hurst (HE) em séries temporais de 1.000 intervalos RR do eletrocardiograma captados na véspera da operação, com equipamento Polar S810i. Resultados: Os respectivos valores de corte determinados com auxílio da curva ROC foram para: DFA total, &#945;1, &#945;2, Entropia aproximada, Expoente de Lyapunov, Tau, Tau normalizado e HE respectivamente: &#61619;1, 036917, &#61619; 0, 727273, &#61619; 0, 906397, &#61603; 0, 480176, &#61603; 0, 832, &#61603; 28, 23143, &#61619;11, 312504, &#61603; 0,210447. No domínio do caos, a DFA total, Tau normalizado, Entropia Aproximada e Expoente Lyapunov no período pré-operatório, se associaram com a ocorrência de infecções pulmonares no pós-operatório de revascularização do miocárdio com P =0, 0309, P=0, 0232, P= 0,0307 e P= 0,0006 respectivamente. Em conclusão, os métodos de dinâmica não-linear, nos seus respectivos níveis de corte, permitiram diferenciar os casos que evoluíram com infecção pulmonar no período pós-operatório de cirurgia de revascularização do miocárdio.

INTRODUÇÃO: Complicações pulmonares são frequentes no pós-operatório da cirurgia de revascularização do miocárdio (RM) e a ventilação não-invasiva (VNI) tem sido utilizada nos cuidados pós-operatórios de forma profilática e terapêutica. A manobra de recrutamento alveolar (MRA) consiste no aumento sustentado de pressão na via aérea utilizando um alto nível de pressão expiratória final positiva (PEEP) em indivíduos hipoxêmicos, garantindo uma ventilação pulmonar homogênea e, com isso melhorando a oxigenação arterial. O objetivo desse estudo foi de avaliar se o uso da VNI associada à MRA pode melhorar a oxigenação e se pode ser aplicada de forma segura nos pacientes pós-operatório de RM. MÉTODOS: Foram incluídos 34 pacientes internados na unidade de terapia intensiva (UTI) ventilados mecanicamente após RM com relação Pa02/Fi02 < 300 e escore radiológico de atelectasia ;:: 2. Os pacientes foram randomizados 16 para o grupo controle (GC) e 18 para o grupo recrutamento (GR), após a extubação a VNI foi aplicada por 30 minutos três vezes ao dia de acordo com a rotina da UTI. No GC a VNI era realizada com PEEP de 8 cm H20 e no GR foi aplicada PEEP de 15 cm H20 e 20 cm H20 durante 2 minutos cada e depois ficava com PEEP de 8 cm H20. Analisamos a Pa02 pela gasometria arterial em ar ambiente e o escore radiológico de atelectasia, estabilidade hemodinâmica e evento adverso até a alta da UTI. RESULTADOS: Aumento de Pa02 12,6 ± 6,8% GC e 23,3 ± 8,5% GR com p < 0,001, o escore radiológico de atelectasia apresentou resolução completa em 94,4% GR, enquanto que no GC, 87,5% apresentou algum grau de atelectasia, p < 0,001. Não houve eventos adversos relacionados. CONCLUSÃO: o uso por 30 minutos da VNI associada à MRA foi seguro, melhorou a oxigenação e reduziu a atelectasia / BACKGROUND: Postoperative pulmonary impairment is common in the early period after coronary artery bypass grafting (CABG) and noninvasive ventilation (NIV) has been used in postoperative care to prevent and treatment. Recruitment maneuver (RM) consists in a sustained raise of airway pressure with high levei of positive end-expiratory pressure (PEEP) in hypoxemic subjects, insuring a homogeneous pulmonary ventilation and enhancing oxygenation. The aims of this study were to evaluate if the use of NIV associated with RM could improve oxygenation and if it could be safely applied in CABG postoperative patients. METHODS: Were included 34 patients admitled to the intensive care unit (ICU) mechanically ventilated after CABG with Pa02/Fi02 ratio < 300 and radiological atelectasis score (RAS) ~ 2. Patients were randomized 16 to the control group (CG) and 18 to the recruitment group (RG), after extubation NIV was applied for 30 minutes three times a day according to ICU routine. In the CG, NIV was performed with PEEP 8 cm H20 and in the RG, was applied PEEP 15 cm H20 and 20 cm H20 for 2 minutes each and then was with PEEP 8 cm H20. We analyzed Pa02 from arterial blood gas at room air and RAS, hemodynamic stability and adverse event until discharged from the ICU. RESUL TS: Increased of Pa02 12.6±6.8% CG and 23.3±8.5% RG p < 0,001, RAS presented complete improvement for 94.4% RG, whereas in the CG, 87.5% presented some degree of atelectasis, p < 0,001. There was no adverse event related. CONCLUSION: The use of 30 minutes of NIV associated with RM was safe, improved oxygenation and reduced atelectasis

Introdução: Pacientes com doença renal crônica (DRC) têm maior probabilidade de desenvolver complicações no pós-operatório. O efeito da N-acetilcisteína (NAC) na prevenção da lesão renal aguda (LRA) associada à cirurgia cardíaca é controvertido. As principais causas desta controvérsia residem na não uniformidade dos critérios para definir a LRA e nas doses da NAC empregadas. Objetivos: O objetivo primário foi avaliar o efeito renoprotetor da NAC em pacientes com DRC durante as primeiras 72 horas depois de cirurgia de revascularização miocárdica eletiva, recorrendo à classificação AKIN, um critério de diagnóstico internacionalmente validado, para definir a LRA e utilizando doses de máximas de NAC sancionadas para uso clínico. Os objetivos secundários foram verificar o impacto do tratamento sobre o estresse oxidativo, morbimortalidade, necessidade de diálise durante a internação e sobre outros marcadores envolvidos na fisiopatologia da LRA. Métodos: estudo prospectivo e duplo-cego em 70 pacientes com DRC estágios 3 e 4 submetidos à revascularização miocárdica cirúrgica eletiva aleatorizados para receber NAC 150 mg/kg IV (dose de ataque) iniciada 2 h antes da cirurgia, seguida por 50 mg/kg IV em 6 horas (grupo NAC) ou solução de NaCl 0,9% IV (grupo Controle). Resultados: A incidência da LRA foi reduzida no grupo NAC (57,1% versus 28,6%, p=0,016). O não uso da NAC (RR= 5,98 IC 95% -2,86 A -0,28, P= 0,015) e a circulação extracorpórea (CEC) (RR= 6,39, IC 95% -2,98 a -0,34, p= 0,012) foram preditores independentes da LRA. Em pacientes tratados com CEC a NAC reduziu o risco de LRA de 63% para 46%. Nos Controles o estresse oxidativo foi elevado (p= 0,01) nas 72 h de pós-operatório. No grupo NAC esta resposta foi abolida. Outros marcadores da LRA foram também mais elevados nos Controles: Cistatina C (p< 0,001) e Neutrophil Gelatinase Associated Lipocalin , NGAL (p= 0,002). Os níveis de proteína C reativa e a incidência da morbimortalidade foram semelhantes entre os grupos. Nenhum paciente necessitou de diálise. Conclusões: A NAC, empregada em doses máximas, reduz a incidência de LRA em pacientes com DRC submetidos à cirurgia de revascularização miocárdica, abole a resposta do estresse oxidativo associado à ocorrência da LRA e reduz o impacto negativo da CEC na função renal / Introduction: Post-operative complications are frequent among patients with chronic kidney disease (CKD). The renoprotective effect of N-acetylcysteine (NAC) in patient undergoing myocardial revascularization is controversial, mainly because of differences in the doses of NAC administered and to different criteria to define acute kidney injury (AKI). Objectives: The primary objective was to evaluate the renoprotective effect of NAC in patients with CKD, stages 3 or 4, undergoing elective coronary artery bypass graft (CABG), with or without cardiopulmonary bypass (CPB), during the first 72 h post-operative. We used a validated criterion to define AKI (AKIN classification) and a maximum IV dose of NAC sanctioned for clinical use. The secondary objectives were to assess the effect of NAC on oxidative stress and other surrogate markers of renal lesion (C Cystatin and Neutrophil Gelatinase Associated Lipocalin, NGAL) and on morbimortality and the need of post-operative dialysis during hospitalization. Methods: this was a prospective double-blind study in 70 stages 3 or 4 CKD patients undergoing CABG randomized to receive either NAC 150 mg/kg IV (induction) started 2 h before surgery, followed by 20 mg/kg IV for 6 h (group NAC) or 0.9 saline IV (group Control). Results: The incidence of AKI was reduced in the group NAC (57.1% versus 28.6%, p=0.016). Non use of NAC (RR= 5.98 95% IC -2.86 to -0.28, p= 0.015) e CPB (RR= 6.39, 95% IC -2.98 to -0.34, p= 0.012) were independent predictors of AKI. NAC also reduced the incidence of AKI from 63% to 46% in patients treated with CPB. Oxidative stress was increased in the Control group (p= 0.01) while it was abolished in patients receiving NAC. Circulating C Cystatin (p< 0.001) and NGAL (p= 0.002) were also reduced by NAC. C-reactive protein and the incidence of death and cardiovascular events were not influenced by NAC. No patient needed dialysis during hospitalization. Conclusions: Maximum IV doses of NAC reduces the incidence of AKI in patients with pre-existing CKD undergoing elective CABG, abolishes oxidative stress and mitigate the negative effect of CPB on renal function

Introdução: Nos pacientes coronarianos, portadores de disfunção ventricular esquerda (DVE), a mortalidade cirúrgica da revascularização miocárdica é 3 a 4 vezes maior do que a encontrada em pacientes com função ventricular normal, sendo fundamental a seleção daqueles que efetivamente poderão ser beneficiados pela cirurgia. As metanálises indicam que a pesquisa da viabilidade miocárdica é útil nesta seleção, impactando em melhora da contratilidade ventricular e redução de mortalidade quando a revascularização é realizada em pacientes com ventrículo esquerdo viável; entretanto, os estudos clínicos randomizados não encontraram os mesmos resultados. Isso porque, apesar de 50% desses pacientes apresentarem quantidades substanciais de viabilidade miocárdica, nem todos conseguem melhorar a contratilidade ventricular esquerda após a revascularização, devido à existência de outros fatores que interferem nessa melhora. Objetivos: Determinar os fatores preditores de melhora da contratilidade ventricular esquerda em pacientes com fração de ejeção < 50% submetidos à cirurgia de revascularização miocárdica (CRM) isolada e o tempo necessário para a ocorrência dessa melhora contrátil. Métodos: Estudo prospectivo observacional que avaliou pacientes coronarianos com DVE submetidos a eletrocardiograma e ecocardiograma no pré-operatório e 1, 3, 6, 9 e 12 meses após a CRM, e à ressonância magnética cardíaca (RMC) com estresse farmacológico com dipiridamol e realce tardio com gadolínio no pré-operatório e após 3 e 12 meses da revascularização, buscando associações entre a melhora da contratilidade ventricular esquerda e as diversas variáveis dos pacientes. Resultados: Foram estudados 306 segmentos miocárdicos de 18 pacientes, com idade de 59,5 + 7,4 anos. Ocorreu melhora contrátil em 47 (29%) segmentos do ventrículo esquerdo que apresentavam alterações contráteis pré-operatórias (p < 0,0001). A análise multivariada identificou três fatores preditores de melhora da contratilidade ventricular esquerda: a ausência de onda Q patológica, que aumenta em 172% a chance de melhora, a presença de viabilidade miocárdica, que aumenta em 282% a chance de melhora e a ausência de isquemia miocárdica, que aumenta em 392% a chance de melhora (razão de chances 2,72, IC 95%, 1,24 a 5,92, p = 0,012; razão de chances 3,82, IC 95%, 1,79 a 8,16, p = 0,0005; e razão de chances 4,92, IC 95%, 2,13 a 11,36, p = 0,0002, respectivamente). Em 9 (75%) pacientes a melhora da contratilidade ventricular ocorreu nos 3 primeiros meses após a CRM e em 3 (25%) pacientes ocorreu nos 9 meses seguintes Conclusões: Os três fatores preditores de melhora da contratilidade ventricular esquerda encontrados foram a ausência de onda Q patológica no eletrocardiograma, e a presença de viabilidade e ausência de isquemia miocárdicas na RMC. A recuperação da contratilidade ventricular esquerda ocorreu predominantemente nos 3 primeiros meses após a CRM, no entanto foi verificada uma melhora progressiva até o final dos 12 meses de seguimento. / Introduction: In patients with coronary artery disease (CAD) and left ventricular dysfunction, the surgical mortality from coronary artery bypass graft (CABG) is 3 to 4 times higher than that reported for patients with normal ventricular function, and selecting those who can effectively benefit from the surgery is essential. Meta-analyses have indicate that myocardial viability assessment is useful in this selection, impacting on left ventricular contractility improvement and mortality reduction when revascularization is performed in patients with viable left ventricles; However, randomized clinical trials have not found the same results. Although 50% of these patients have substantial myocardial viability, not all of them can improve left ventricular contractility after revascularization, due to other factors that interfere with this improvement. Objectives: This study aims to determine the predictors of improvement in left ventricular contractility in patients with an ejection fraction of <50% who underwent isolated CABG, as well as the time required for this improvement in contractility. Methods: This prospective observational study assessed patients with CAD and left ventricular dysfunction who underwent electrocardiography and echocardiography during the preoperative period and 1, 3, 6, 9, and 12 months after CABG and cardiac magnetic resonance with pharmacological stress with dipyridamole and late gadolinium enhancement in the preoperative period and 3 and 12 months after revascularization, to determine the associations between the evolution of left ventricular contractility and several patient-related variables. Results: A total of 306 myocardial segments of the 18 patients, aged 59.5 ± 7.4 years, were studied. There was a contractile improvement in 47 (29%) segments of the left ventricle that presented preoperative contractile abnormalities (p < 0.0001). The multivariate analysis identified three predictors of left ventricular contractility improvement: the absence of pathological Q waves, which increases the chance of improvement by 172% (odds ratio (OR) 2.72, 95% confidence interval (CI), 1.24-5.92, p = 0.012), the presence of myocardial viability, which increases the chance of improvement by 282% (OR 3.82, 95% CI, 1.79-8.16, p = 0.0005), and the absence of myocardial ischemia, which increases the chances of improvement by 392%, (OR 4.92, 95% CI, 2.13-11.36, p = 0.0002). In 9 (75%) patients the improvement in ventricular contractility occurred in the first 3 months after CABG, and in 3 (25%) patients, it occurred in the following 9 months. Conclusions: The three predictors of left ventricular contractility improvement were the absence of pathological Q waves on an electrocardiogram, the presence of myocardial viability and the absence of signs of ischemia on cardiac MRI. The improvement in left ventricular contractility occurred predominantly in the first three months after CABG, but a progressive recovery was observed until the end of the 12-month follow-up period.